rpcardioRational Pharmacotherapy in CardiologyРациональная Фармакотерапия в Кардиологии1819-64462225-3653«SILICEA-POLIGRAF» LLCrpcardio-1071Research ArticlePOINT OF VIEWТОЧКА ЗРЕНИЯEDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL”КОММЕНТАРИЙ РЕДАКЦИИ К СТАТЬЕ М.Н. МАМЕДОВА И М.В. СТРОЕВОЙ «НА ЧТО МОЖНО РАССЧИТЫВАТЬ ПРИ ИСПОЛЬЗОВАНИИ ИНГИБИТОРА АПФ РАМИПРИЛА У ЛИЦ С ВЫСОКИМ СЕРДЕЧНО-СОСУДИСТЫМ РИСКОМ И РАННИМИ НАРУШЕНИЯМИ УГЛЕВОДНОГО ОБМЕНА: УРОКИ ИССЛЕДОВАНИЯ DREAM»РедакционнаястатьяРедакционнаястатья200825012016419191Copyright © Редакционная с., 20162016Редакционная с.Редакционная с.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.rpcardio.online/jour/article/view/1071
.
.
ReferencesThe DREAM Trial Investigators. Effect of ramipril on the incidence of diabetes. N Engl J Med 2006;355:1551-62.The DREAM Trial Investigators. Effect of ramipril on the incidence of diabetes. N Engl J Med 2006;355:1551-62.The DREAM Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 2006;368:1096- 105.The DREAM Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 2006;368:1096- 105.Toumilechto J, Lindstr m J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.Toumilechto J, Lindstr m J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.ESC/EASD guidelines on diabetes, pre-diabetes and cardiovascular diseases. Eur Heart J 2007;28:88-136.ESC/EASD guidelines on diabetes, pre-diabetes and cardiovascular diseases. Eur Heart J 2007;28:88-136.
The authors declare that there are no conflicts of interest present.